In a major relief for patients, the prices of one hundred thirty seven cancer drugs are set to drop significantly across the country. The National Pharmaceutical Pricing Authority has capped trade margins at thirty percent under special provisions. This crucial decision includes patented medications to curb excessive costs, making essential treatments much more affordable and accessible for families fighting against the disease nationwide.
